Royal Caribbean Cruises Ltd vs Revvity Inc — how do they compare? Royal Caribbean Cruises Ltd trades at $285.5 (market cap $76.75B), while Revvity Inc trades at $110.67 (market cap $12.33B). The key difference: Royal Caribbean Cruises Ltd is far larger — about 6.2× Revvity Inc's market cap, and Royal Caribbean Cruises Ltd pays the higher dividend (1.75%). Which is the better fit depends on your goals.
| RCL | RVTY | |
|---|---|---|
Market Cap | $76.75B | $12.33B |
Sector | Consumer Cyclical | Technology |
52-Week High | $365.84 | $117.75 |
52-Week Low | $246.71 | $82.26 |
Enterprise Value | $98.03B | $14.82B |
Dividend Yield | 1.75% | 0.25% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
RVTY trades at $106.44, down 3.37% today, with a bullish technical outlook despite near-term weakness. The company maintains stable revenue around $2.9B with consistent earnings beats, though valuation multiples appear elevated with a P/E of 51. Recent AI product launches and FDA clearances demonstrate innovation in life sciences and diagnostics. Analyst consensus remains positive with a $111.43 price target and no sell ratings among 29 covering firms.
The stock presents a growth opportunity with strong analyst support and technological innovation, but faces risks from margin pressure and China market exposure. Current levels near support at $105 offer potential entry, though the high P/E requires sustained earnings growth to justify valuation. Upcoming Q2 earnings on August 4, 2026 will be critical for near-term direction.
Trailing returns across standard periods
Latest headlines on both assets
Royal Caribbean is the world's second-largest cruise company, operating 64 ships across five global and partner brands in the cruise vacation industry, with 10 more ships on order. Brands the company operates include Royal Caribbean International, Celebrity Cruises, and Silversea. The company also has a 50% investment in a joint venture that operates TUI Cruises and Hapag-Lloyd Cruises, allowing it to compete on the basis of innovation, quality of ships and service, variety of itineraries, choice of destinations, and price. The company completed the divestiture of its Azamara brand in the first quarter of 2021.
Read more on RCL →Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →